Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 4—April 2006

Economic Impact of Lyme Disease

Xinzhi Zhang*Comments to Author , Martin I. Meltzer*, César A. Peña†1, Annette B. Hopkins†, Lane Wroth‡, and Alan D. Fix†
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †University of Maryland, Baltimore, Maryland, USA; ‡Care First-Easton Branch (previously Delmarva Health Plan), Easton, Maryland, USA

Main Article

Table 1

Reported cases* of Lyme disease (LD) in Maryland Eastern Shore, 1997–2000†

County 1997 1998 1999 2000 Total
Caroline 18 17 26 21 82
Dorchester 3 4 3 4 14
Kent 24 47 20 34 125
Queen Anne 32 31 40 35 138
Talbot 13 22 33 37 105
Total 90 121 122 131 464

*Reported cases defined according to the national surveillance definition. For the purpose of surveillance, a case of LD is defined as physician-diagnosed erythema migrans >5 cm or >1 late rheumatologic, neurologic, or cardiac manifestation with laboratory evidence of Borrelia burgdorferi infection.
†Source: Maryland Department of Health and Mental Hygiene. Available from

Main Article

1Current affiliation: Maryland Department of Health and Mental Hygiene, Baltimore, Maryland, USA

Page created: January 19, 2012
Page updated: January 19, 2012
Page reviewed: January 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.